Gabby Landsverk
Gabby Landsverk is a health and science reporter for Insider. She covers a wide range of topics including nutrition, fitness, and general health news. Her work is well-researched and based on scientific studies, ensuring a high level of accuracy and reliability.
99%
The Daily's Verdict
This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.
Bias
100%
Examples:
No current examples available.
Conflicts of Interest
100%
Examples:
No current examples available.
Contradictions
100%
Examples:
No current examples available.
Deceptions
100%
Examples:
No current examples available.
Recent Articles
Colorectal Cancer Surges in Young Adults: Tripled Cases in Teenagers and Doubled in Those Aged 20-24 Over the Last Two Decades
Broke On: Thursday, 09 May 2024Recent studies reveal a striking increase in colorectal cancer cases among teenagers and young adults, with cases tripling for those aged 10-14 and doubling for 20-24 year olds over the last two decades. The study led by Dr. Islam Mohamed highlights the need for increased awareness, better treatment, and prevention options for younger age groups. Plant-Based Protein May Keep Women Healthier as They Age: Study Finds
Broke On: Thursday, 18 January 2024A new study in the American Journal of Clinical Nutrition reveals that a diet high in plant-based protein may boost women's health as they age. For every 3% increase in plant protein, women had a 38% higher chance of maintaining their health, free from chronic diseases and cognitive decline. The research analyzed data from over 48,000 women and found that those with diets rich in legumes, whole grains, nuts/seeds had better health outcomes than meat-based protein consumers. Recent Studies Highlight New Approaches and Insights in Blood Pressure Management
Broke On: Tuesday, 14 November 2023Chronic insufficient sleep can increase insulin resistance in healthy women, particularly postmenopausal women. Alnylam Pharmaceuticals has developed an RNA interference treatment, zilebesiran, which has shown to reduce blood pressure for six months with one to two doses in a mid-stage clinical trial. Reducing sodium intake can help lower blood pressure as effectively as medication. A systolic blood pressure treatment target under 120 mm Hg improves outcomes and saves lives compared with a threshold of 140 mm Hg for higher risk patients with hypertension.